Hep-Lock Solution For Injection 100U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Hep-Lock: Solution for injection (100U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


In-Depth Information
Select a Medication

Hep-Lock 100unit/ml Solution for Injection

NDC: 006412436
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Arterial Thromboembolism, Pulmonary Embolism Prophylaxis, Pulmonary Embolism, Coronary Artery Thrombosis Prophylaxis, Disseminated Intravascular Coagulation (DIC), Cerebral Thromboembolism, Unstable Angina, Prosthetic Heart Valves, Deep Venous Thrombosis (DVT), Arterial Thromboembolism Prophylaxis, Deep Venous Thrombosis (DVT) Prophylaxis, Percutaneous Coronary Intervention (PCI), Antiphospholipid Antibody Syndrome, Mural Thrombosis, Mural Thrombosis Prophylaxis, Thrombosis Prophylaxis, Acute Myocardial Infarction

Sometimes used for but not FDA approved for the following conditions:
Intravascular Catheter Occlusion Prophylaxis, Periprocedural Anticoagulation

Storage Information
Store in a cool, dry place
Store at controlled room temperature (between 68 and 77 degrees F)
Hep-Lock 100unit/ml Solution for Injection

Reported Side Effects for Hep-Lock 100unit/ml Solution for Injection

Low Platelet Count Incidence:
<30.0%*
Severity: MODERATE
Onset: DELAYED
Broken Bones Incidence:
2.0-3.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Second Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Third Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Hep-Lock

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5